Literature DB >> 7733942

Species difference in the binding characteristics of RES-701-1: potent endothelin ETB receptor-selective antagonist.

T Tanaka1, T Ogawa, Y Matsuda.   

Abstract

Species-dependency of RES-701-1 (cyclic (Gly1-Asp9)(Gly-Asn-Trp-His-Gly-Thr-Ala-Pro-Asp-Trp-Phe-Phe- Asn-Tyr-Tyr-Trp)) has been shown using 125I-ET-1 binding to membranes from various animal tissues. RES-701-1 selectively inhibited the 125I-ET-1 binding to ETB receptor from canine, rabbit, porcine, and guinea pig lung tissues in a dose-dependent manner with IC50 values of 60 nM, 20, 4 nM and 13 nM, respectively. Though RES-701-1 retained selectivity for ETB receptor even at higher concentrations, RES-701-1 inhibited the 125I-ET-1 binding to ETB receptor from rat lung, heart, and kidney only weakly; IC50 values were calculated to be 1.2 microM, 0.9 microM and 0.6 microM, respectively. These results suggest that RES-701-1 is a potent and specific antagonist for ETB receptor in various species of animal, and would be a powerful tool for understanding the physiological roles of ETB receptor, but care must be taken in use of RES-701-1 in experiments with rat.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733942     DOI: 10.1006/bbrc.1995.1557

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Characterization of the binding of endothelin ETB selective ligands in human and rat heart.

Authors:  F D Russell; A P Davenport
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

2.  Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.

Authors:  D W Hay; M A Luttmann; G Beck; E H Ohlstein
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

Review 3.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.